Phase 3 OASIS Study Shows Promise of Oral Olorofim for Invasive Aspergillosis by Chad Birt| Published on: Nov 10, 2026

Phase 3 OASIS Study Shows Promise of Oral Olorofim for Invasive Aspergillosis by Chad Birt| Published on: Nov 10, 2026 Johan Maertens, MD, PhD, Professor of Hematology at University Hospitals Leuven (UZ Leuven) in Belgium and Principal Investigator of the OASIS study, discusses positive phase 3 trial results evaluating oral olorofim in patients with invasive aspergillosis. https://checkrare.com/phase-3-oasis-study-shows-promise-of-oral-olorofim-for-invasive-aspergillosis/